Laurus Labs enhances CDMO capacity, driving growth in small molecules and biologics, while maintaining strong revenue visibility and premium valuations.
Hosted on MSN
From Laurus Labs To Alkem: SEBI Analysts Spot Bullish Setups In These Five Stocks For Short-Term Trades
Indian equity markets remain in a tight range in the weekly expiry session on Thursday. However, pockets of opportunity are emerging, with SEBI-registered analysts Kavita Agrawal and Vinay Taparia ...
Laurus Labs has seen its consensus analyst price target edge up slightly from ₹815.86 to ₹821.93. This signals renewed confidence among market watchers. This shift comes as experts weigh in on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback